Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $28.12 ($84,360)
  2. 4 Open-market sale Director sold 5,000 shares at $31.93 ($159,642)
  3. 4 Open-market sale Director sold 16,181 shares at $30.00 ($485,466)
  4. 4 Open-market sale Chief Medical Officer sold 16,160 shares at $30.00 ($484,800)
  5. 4 Open-market sale Chief Financial Officer sold 33,000 shares at an average $29.99 ($989,694)
  6. 4 Open-market sale President and CEO sold 19,578 shares at $29.43 ($576,141)
  7. 4 Open-market sale Chief Medical Officer sold 23,840 shares at $30.00 ($715,200)
  8. 4 Open-market sale Director sold 3,819 shares at $30.00 ($114,570)
  9. 5 Insider Annual Insider Trading Report
  10. 4 Open-market sale Chief Financial Officer sold 2,548 shares at $26.69 ($68,010)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale President and CEO sold 6,526 shares at $25.01 ($163,215)
  16. 4 Open-market sale Director sold 10,000 shares at $25.01 ($250,078)
  17. 4 Open-market sale President and CEO sold 13,052 shares at $21.04 ($274,614)
  18. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $21.11 ($52,775)
  19. 4 Open-market sale Director sold 5,000 shares at $22.29 ($111,426)
  20. 4 Exercise or conversion Chief Medical Officer acquired 15,117 shares (option exercise)

Page 13 of 20 · 400 filings